EX-FILING FEES 3 d339256dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Heart Test Laboratories, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
    

Security 

Type 

  Security
Class Title
 

Fee Calculation or 

Carry Forward 

Rule 

 

Amount 

Registered (1) 

 

Proposed Maximum 

Offering Price Per Unit 

(2) 

 

Maximum Aggregate Offering 

Price (2)

  Fee Rate   Amount of Registration Fee
Fees to be Paid   Equity   Common Stock, par value $0.001 per share   457(c)   1,544,114   $1.405   $2,169,480.17   0.0000927   $201.11
Fees to be Paid   Equity   Common Stock, par value $0.001 per share, issuable upon exercise of Bridge Warrants issued in private placement from December 2021 to February 2022   457(c)   1,683,470   $1.405   $2,365,275.35   0.0000927   $219.26
Fees to be Paid   Equity   Common Stock, par value $0.001 per share, issuable upon exercise of Pre-Funded Warrants   457(c)      139,356   $1.405   $   195,795.18   0.0000927   $  18.15
        Total Offering Amounts:       $4,730,550.70       $438.52
    Total Fees Previously Paid:                     —  
                     Total Fee Offsets:               $613.68
    Net Fee Due:                $         0

 

(1)

This registration statement also relates to such additional shares of Common Stock, par value $0.001 per share (“Common Stock”), as may be issued in connection with a stock split, stock dividend, recapitalization, or similar transaction effected without receipt of consideration that increases the number of the registrant’s outstanding shares of Common Stock, pursuant to Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”).

(2)

Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is the average of the high and low prices reported for the registrant’s Common Stock quoted on The Nasdaq Stock Market on September 8, 2022.


Table 2: Newly Registered Securities

 

     Registrant or
Filer Name
   Form
or
Filing
Type
   File Number    Initial
Filing
Date
   Filing
Date
   Fee
Offset
Claimed
   Security
Type
Associated
with Fee
Offset
Claimed
   Security Title Associated with Fee Offset Claimed    Unsold
Securities
Associated
with Fee
Offset
Claimed
   Unsold
Aggregate
Offering
Amount
Associated with
Fee Offset
Claimed
   Fee Paid
with Fee
Offset
Source

Rule 457(p)

Fee Offset Claims    Heart Test
Laboratories,
Inc.
   S-1    333-265024    May 17,
2022
        $335.83    Other    Units, each consisting of one share of Common Stock, par value $0.001 per share, and one Warrant    852,412    $3,622,750.00     
Fee Offset Sources    Heart Test
Laboratories,
Inc.
   S-1    333-265024         June 13,
2022
                            $335.83
Fee Offset Claims    Heart Test
Laboratories,
Inc.
   S-1    333-265024    May 17,
2022
        $247.39    Equity    Shares of Common Stock, par value $0.001 per share, underlying Warrants included in the Units (plus Warrants sold pursuant to over-allotment option)    627,941    $2,668,750.00     
Fee Offset Sources    Heart Test
Laboratories,
Inc.
   S-1    333-265024         June 13,
2022
                            $247.39
Fee Offset Claims    Heart Test
Laboratories,
Inc.
   S-1    333-265024    May 17,
2022
        $30.46    Equity    Shares of common stock, par value $0.001 per share, underlying Representative’s warrants    77,309    $328,562.50     
Fee Offset Sources    Heart Test
Laboratories,
Inc.
   S-1    333-265024         June 13,
2022
                            $30.46